Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darcy A Krueger

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Treatment Options in Neurology|July 16, 2013
Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis ComplexDarcy A Krueger
Pediatric Neurology|September 24, 2013
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferenceDarcy A Krueger, Hope Northrup,
Pediatric Neurology|September 24, 2013
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus ConferenceHope Northrup, Darcy A Krueger,
Neuro-Oncology|August 21, 2015
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complexJeffrey P MacKeigan, Darcy A Krueger
Paediatric Drugs|August 30, 2008
Current management of tuberous sclerosis complexDarcy A Krueger, David N Franz
Seizure|December 15, 2010
Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndromeHansel Greiner, James L Leach, Ki-Hyeong Lee, et al.
Current Medical Research and Opinion|December 15, 2018
Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytomaXue Song, Qayyim Said, Oth Tran, et al.
Trends in Neurosciences|March 22, 2025
Somatic mosaicism and interneuron involvement in mTORopathiesLilian G Jerow, Darcy A Krueger, Christina Gross, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 20, 2015
Tuberous Sclerosis: A New Frontier in Targeted Treatment of AutismPeter E Davis, Jurriaan M Peters, Darcy A Krueger, et al.
Neurology|January 21, 2012
Everolimus alters white matter diffusion in tuberous sclerosis complexJan-Mendelt Tillema, James L Leach, Darcy A Krueger, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Treatment Options in Neurology|July 16, 2013
Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis ComplexDarcy A Krueger
Pediatric Neurology|September 24, 2013
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus ConferenceDarcy A Krueger, Hope Northrup,
Pediatric Neurology|September 24, 2013
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus ConferenceHope Northrup, Darcy A Krueger,
Neuro-Oncology|August 21, 2015
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complexJeffrey P MacKeigan, Darcy A Krueger
Paediatric Drugs|August 30, 2008
Current management of tuberous sclerosis complexDarcy A Krueger, David N Franz
Seizure|December 15, 2010
Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndromeHansel Greiner, James L Leach, Ki-Hyeong Lee, et al.
Current Medical Research and Opinion|December 15, 2018
Everolimus compliance and persistence among tuberous sclerosis complex patients with renal angiomyolipoma or subependymal giant cell astrocytomaXue Song, Qayyim Said, Oth Tran, et al.
Trends in Neurosciences|March 22, 2025
Somatic mosaicism and interneuron involvement in mTORopathiesLilian G Jerow, Darcy A Krueger, Christina Gross, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|May 20, 2015
Tuberous Sclerosis: A New Frontier in Targeted Treatment of AutismPeter E Davis, Jurriaan M Peters, Darcy A Krueger, et al.
Neurology|January 21, 2012
Everolimus alters white matter diffusion in tuberous sclerosis complexJan-Mendelt Tillema, James L Leach, Darcy A Krueger, et al.
Pageof 9